Correlations among steroid fear, acceptability, usage frequency, quality of life and disease severity in childhood eczema

Journal of Dermatological Treatment

Volumn 26, Issue 5, 2015, Pages 418-425

  Hon, Kam Lun ^a   Tsang, Yin Ching K ^a   Pong, Nga Hin ^a   Luk, David C K ^b   Lee, Vivian W ^a   Woo, Wing Man ^c   Lam, Chak Yiu Justin ^c   Yeung, Yun Ting Eunice ^c   Chau, Yiu Shing Sunny ^c   Chui, Ka Kam Kenneth ^c   Li, Ka Hin Gabriel ^c   Leung, Ting Fan ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNITED CHRISTIAN HOSPITAL   (Hong Kong)

^c Prince of Wales Hospital   (Hong Kong)

Author keywords

Acceptability; CDLQI; eczema; glucocorticoid fears; NESS

Indexed keywords

CORTICOSTEROID; GLUCOCORTICOID;

ARTICLE; BONE DISEASE; CAREGIVER; CHILD; CHILDHOOD; CHILDREN DERMATOLOGY LIFE QUALITY INDEX; CHINESE MEDICINE; DERMATOLOGY LIFE QUALITY INDEX; DISEASE SEVERITY; ECZEMA; EYE DISEASE; FEAR; FEMALE; HEALTH SURVEY; HERBAL MEDICINE; HUMAN; KIDNEY DISEASE; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; NOTTINGHAM ECZEMA SEVERITY SCORE; OUTPATIENT DEPARTMENT; PARENT; PHYSICIAN; PRIORITY JOURNAL; QUALITY OF LIFE; SKIN MANIFESTATION; UNIVERSITY HOSPITAL; ADOLESCENT; ATTITUDE TO HEALTH; DERMATOLOGY; INFLAMMATION; OBSERVER VARIATION; PATIENT EDUCATION; PATIENT PARTICIPATION; PRESCHOOL CHILD; PROCEDURES; PSYCHOLOGY; QUESTIONNAIRE; SEVERITY OF ILLNESS INDEX; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ADOLESCENT; ATTITUDE TO HEALTH; CAREGIVERS; CHILD; CHILD, PRESCHOOL; DERMATOLOGY; ECZEMA; FEAR; FEMALE; GLUCOCORTICOIDS; HUMANS; INFLAMMATION; MALE; OBSERVER VARIATION; PARENTS; PATIENT EDUCATION AS TOPIC; PATIENT PARTICIPATION; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; SURVEYS AND QUESTIONNAIRES;

EID: 84942058667     PISSN: 09546634     EISSN: 14711753     Source Type: Journal    
DOI: 10.3109/09546634.2015.1025030     Document Type: Article

References (32)

1. Foley P, Zuo Y, Plunkett A, Marks R. The frequency of common skin conditions in preschool-age children in Australia: atopic dermatitis. Arch Dermatol. 2001;137:293-300
2. Leung R, Wong G, Lau J, et al. Prevalence of asthma and allergy in Hong Kong schoolchildren: an ISAAC study. Eur Respir J. 1997;10: 354-60
3. Emerson RM, Williams HC, Allen BR. Severity distribution of atopic dermatitis in the community and its relationship to secondary referral. Br J Dermatol. 1998;139:73-6
4. Leung AK, Hon KL, Robson WL. Atopic dermatitis. Adv Pediatr. 2007;54:241-73
5. Hon KL, Pong NH, Wang SS, et al. Acceptability and efficacy of an emollient containing ceramide-precursor lipids and moisturizing factors for atopic dermatitis in pediatric patients. Drugs R D. 2013; 13:37-42
6. Hon KL, Wang SS, Pong NH, Leung TF. The ideal moisturizer: a survey of parental expectations and practice in childhood-onset eczema. J Dermatolog Treat. 2012;24:7-12
7. Hon KL, Ching GK, Leung TF, et al. Estimating emollient usage in patients with eczema. Clin Exp Dermatol. 2010;35:22-6
8. Hon KL, Leung TF, Kam WY, et al. Dietary restriction and supplementation in children with atopic eczema. Clin Exp Dermatol. 2006;31:187-91
9. Hon KL, Wang SS, Lau Z, et al. Pseudoceramide for childhood eczema: does it work? Hong Kong Med J. 2011;17:132-6
10. Hon KL, Leung AK. Use of ceramides and related products for childhood-onset eczema. Recent Pat Inflamm Allergy Drug Discov. 2012;1:12-19
11. Hon KL, Leung TF, Lam MC, et al. Eczema exacerbation and food atopy beyond infancy: how should we advise Chinese parents about dietary history, eczema severity, and skin prick testing? Adv Ther. 2007;24:223-30
12. Hon KL, Leung TF, Yau HC, Chan T. Paradoxical use of oral and topical steroids in steroid-phobic patients resorting to traditional Chinese medicines. World J Pediatr. 2012;8:263-7
13. Patterson R, Walker CL, Greenberger PA, Sheridan EP. Prednisonephobia. Allergy Proc. 1989;10:423-8
14. Charman C, Williams H. Outcome measures of disease severity in atopic eczema. Arch Dermatol. 2000;136:763-9
15. Hon KL, Kam WY, Leung TF, et al. Steroid fears in children with eczema. Acta Paediatrica. 2006;95:1451-5
16. Aubert-Wastiaux H, Moret L, Le Rhun A, et al. Topical corticosteroid phobia in atopic dermatitis: a study of its nature, origins and frequency. Br J Dermatol. 2011;165:808-14
17. Kojima R, Fujiwara T, Matsuda A, et al. Factors associated with steroid phobia in caregivers of children with atopic dermatitis. Pediatr Dermatol. 2013;30:29-35
18. Moret L, Anthoine E, Aubert-Wastiaux H, et al. TOPICOP(c): a new scale evaluating topical corticosteroid phobia among atopic dermatitis outpatients and their parents. PLoS One. 2013;8: e76493
19. Williams HC, Burney PG, Pembroke AC, Hay RJ. The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis. III. Independent hospital validation. Br J Dermatol. 1994;131: 406-16
20. Emerson RM, Charman CR, Williams HC. The Nottingham Eczema Severity Score: preliminary refinement of the Rajka and Langeland grading. Br J Dermatol. 2000;142:288-97
21. Hon KL, Ma KC, Wong E, et al. Validation of a self-administered questionnaire in Chinese in the assessment of eczema severity. Pediatr Dermatol. 2003;20:465-9
22. Chuh AA. Validation of a Cantonese version of the Children's Dermatology Life Quality Index. Pediatr Dermatol. 2003;20:479-81
23. Hon KL, Kam WY, Lam MC, et al. CDLQI, SCORAD and NESS: are they correlated? Qual Life Res. 2006;15:1551-8
24. Waters A, Sandhu D, Beattie P, et al. Severity stratification of Children's Dermatology Life Quality Index (CDLQI) scores. Br J Dermatol. 2010;163:121
25. Hon KL, Wong KY, Leung TF, et al. Comparison of skin hydration evaluation sites and correlations among skin hydration, transepidermal water loss, SCORAD Index, Nottingham Eczema Severity Score, and quality of life in patients with atopic dermatitis. Am J Clin Dermatol. 2008;9:45-50
26. Tang TS, Bieber T, Williams HC. Are the concepts of induction of remission and treatment of subclinical inflammation in atopic dermatitis clinically useful? J Allergy Clin Immunol. 2014;133: 1615-25
27. Torley D, Futamura M, Williams HC, Thomas KS. What's new in atopic eczema? An analysis of systematic reviews published in 2010-11. Clin Exp Dermatol. 2013;38:449-56
28. Schmitt J, von KL, Svensson A, Apfelbacher C. Efficacy and tolerability of proactive treatment with topical corticosteroids and calcineurin inhibitors for atopic eczema: systematic review and meta-analysis of randomized controlled trials. Br J Dermatol. 2011;164:415-28
29. Wollenberg A, Frank R, Kroth J, Ruzicka T. Proactive therapy of atopic eczema-an evidence-based concept with a behavioral background. J Dtsch Dermatol Ges. 2009;7:117-21
30. Ellison JA, Patel LM, Ray DW, et al. Hypothalamic-pituitaryadrenal function and glucocorticoid sensitivity in atopic dermatitis. Pediatrics. 2000;105:794-9
31. Thomas KS, Armstrong S, Avery A, et al. Randomised controlled trial of short bursts of a potent topical corticosteroid versus prolonged use of a mild preparation for children with mild or moderate atopic eczema. BMJ. 2002;324:768
32. Friedlander SF, Hebert AA, Allen DB. Safety of fluticasone propionate cream 0.05% for the treatment of severe and extensive atopic dermatitis in children as young as 3 months. J Am Acad Dermatol. 2002;46:387-93.